Ac Immune Sa (ACIU) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, January 26, 2023

Ac Immune Sa

CIK: 1651625 Ticker: ACIU

View differences made from one to another to evaluate Ac Immune Sa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ac Immune Sa.


Assess how Ac Immune Sa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Ac Immune Sa provided additional information to their SEC Filing as exhibits

Ticker: ACIU
CIK: 1651625
Form Type: 6-K Foreign Issuer Report
Accession Number: 0000950103-23-001048
Submitted to the SEC: Thu Jan 26 2023 7:05:44 AM EST
Accepted by the SEC: Thu Jan 26 2023
Period: Thursday, January 26, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: